Effect of High Altitude Exposure, Acclimatization and Re-exposure on Lung Water Content by Ultrasound
1 other identifier
interventional
21
1 country
1
Brief Summary
Prospective interventional trial in lowlanders evaluating effect of acute exposure, acclimatization and re-exposure to high altitude.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 12, 2016
CompletedFirst Posted
Study publicly available on registry
May 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMay 5, 2017
May 1, 2017
9 months
April 12, 2016
May 4, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
ultrasound lung comets
change from lowland baseline at 520m, day 2 and first sojourn at 5050 m, day 2
Secondary Outcomes (1)
ultrasound lung comets
first sojourn at 5050 m, 7; second sojourn at 5050m, day 2, 7
Study Arms (1)
Altitude Exposure
EXPERIMENTALAcute high altitude exposure followed by 7 day acclimatization and reexposure after 7 days at low altitude
Interventions
Eligibility Criteria
You may qualify if:
- Born, raised and currently living \<800m
- No overnight stay at altitudes \> 1500m 4 weeks before the study
You may not qualify if:
- Previous altitude intolerance to altitude \<3000m
- Pregnancy
- Health impairment, which requires regular treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- University of Calgarycollaborator
Study Sites (1)
Switzerland
Zurich, 8091, Switzerland
Study Officials
- STUDY CHAIR
Konrad E Bloch, MD
University of Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2016
First Posted
May 3, 2016
Study Start
March 1, 2016
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
May 5, 2017
Record last verified: 2017-05